Prashant Nagre

Prashant Nagre has extensive work experience in the pharmaceutical industry. Prashant served as the Chief Executive Officer (CEO) at Fermenta Biotech Ltd, where they led the company in the Vitamin D3 market and pioneered biocatalysis and biotransformation solutions. Prior to that, Nagre was the CEO of Sterling Biotech Limited, where they oversaw the production of Coenzyme Q10 and oncology products. Prashant also held the position of Vice President at Elder Pharmaceuticals Ltd, managing API business and ensuring regulatory compliance. Earlier in their career, Nagre was the Head of Line Alpha at Sandoz India Pvt Ltd.

Prashant Nagre pursued a Post Graduate Diploma in International Trade at the Indian Institute of Foreign Trade, specializing in International Business, Trade, and Tax Law. Prashant completed this program from 1996 to 1997.